Publications by authors named "Brian Soper"

Claim this Profile
I
Impact of antibody Fc engineering on translational pharmacology, and safety: insights from industry case studies.
Frank R Brennan, J Ryan Polli, Jean Sathish, Melissa Ramones, Babette Wolf, Brian Soper

MAbs· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Human Immune Reconstitution, T-Cell Development, and Immune Reactivity in Mice Lacking the Murine Major Histocompatibility Complex: Validation with Cellular and Gene Expression Profiles.
Milita Darguzyte, Philipp Antczak, Daniel Bachurski, Patrick Hoelker, Nima Abedpour, Brian Soper

Cells· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine release syndrome and cancer immunotherapies - historical challenges and promising futures.
Deep Shah, Brian Soper, Lindsay Shopland

Front Immunol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovations, challenges, and minimal information for standardization of humanized mice.
Renata Stripecke, Christian Münz, Jan Jacob Schuringa, Karl-Dimiter Bissig, Brian Soper

EMBO Mol Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonhuman primate event-related potentials associated with pro- and anti-saccades.
Victor Sander, Brian Soper, Stefan Everling

Neuroimage· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow expressing a diabetes resistance MHC class II allele: diabetes deviation by chronic immune stimulation.
Peter Reifsnyder, William Schott, Darcy Pomerleau, Mark D Lessard, Brian W Soper

Novartis Found Symp· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attenuation of murine lysosomal storage disease by allogeneic neonatal bone marrow transplantation using costimulatory blockade and donor lymphocyte infusion without myeloablation.
Mark D Lessard, Travis L Alley, Jennifer L Proctor, Beth Levy, Nancy Galvin, Brian W Soper

Clin Immunol· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early onset of lysosomal storage disease in a murine model of mucopolysaccharidosis type VII: undegraded substrate accumulates in many tissues in the fetus and very young MPS VII mouse.
Carole Vogler, Beth Levy, Nancy Galvin, Mark Lessard, Brian Soper

Pediatr Dev Pathol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of protein kinase C activation on intracellular Ca2+ signaling and integrity of intestinal epithelial cells.
Barry L Tepperman, Brian D Soper, Qing Chang

Eur J Pharmacol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transplanted ER-MP12hi20-58med/hi myeloid progenitors produce resident macrophages from marrow that are therapeutic for lysosomal storage disease.
Brian W Soper, Ted M Duffy, Mark D Lessard, Craig D Jude, Adam J T Schuldt

Blood Cells Mol Dis· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of PKCdelta and PKCepsilon in the neonatal rat colon in response to hypoxia challenge.
Melissa Conte, Brian Soper, Qing Chang, Barry Tepperman

Pediatr Res· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor cell expansion is delayed following nonablative in utero transplantation to treat murine mucopolysaccharidosis type VII.
Jane E Barker, Adam J T Schuldt, Mark L Lessard, Craig D Jude, Carole A Vogler, Brian W Soper

Exp Hematol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful allogeneic neonatal bone marrow transplantation devoid of myeloablation requires costimulatory blockade.
Brian W Soper, Mark D Lessard, Craig D Jude, Adam J T Schuldt, Ralph M Bunte

J Immunol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed administration of carrier marrow can decrease competition on donor stem cells during engraftment and maintain radioprotection of the host.
Brian W Soper, Mark D Lessard, Craig D Jude, Adam J Schuldt, Jane E Barker

Exp Hematol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis